Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.

Grisotto KP, Bruck I, Antoniuk SA, Santos LH.

Arq Neuropsiquiatr. 2008 Sep;66(3A):477-81.

2.

Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.

Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.

Pediatrics. 2006 Aug;118(2):e371-8. Epub 2006 Jul 17.

PMID:
16847080
3.

Lamotrigine and valproate: efficacy of co-administration in a pediatric population.

Thomé-Souza S, Freitas A, Fiore LA, Valente KD.

Pediatr Neurol. 2003 May;28(5):360-4.

PMID:
12878297
4.
5.

Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.

Farrell K, Connolly MB, Munn R, Peng S, MacWilliam LM.

Pediatr Neurol. 1997 Apr;16(3):201-5.

PMID:
9165509
6.

Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.

Moeller JJ, Rahey SR, Sadler RM.

Epilepsia. 2009 Mar;50(3):475-9. doi: 10.1111/j.1528-1167.2008.01866.x. Epub 2008 Nov 19.

7.

[Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].

Arzimanoglou A, Kulak I, Bidaut-Mazel C, Baldy-Moulinier M.

Rev Neurol (Paris). 2001 May;157(5):525-36. French.

PMID:
11438772
8.

Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.

Thome-Souza S, Valente KD.

Pediatr Neurol. 2013 Jun;48(6):436-42. doi: 10.1016/j.pediatrneurol.2013.01.005.

PMID:
23668867
9.

Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.

Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.

Eur J Paediatr Neurol. 2009 Mar;13(2):141-5. doi: 10.1016/j.ejpn.2008.03.002. Epub 2008 Jun 27.

PMID:
18585941
10.

Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.

Posner EB, Mohamed K, Marson AG.

Cochrane Database Syst Rev. 2003;(3):CD003032. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003032.

PMID:
12917940
11.

Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.

Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS.

Neurology. 2001 Jan 23;56(2):172-7.

PMID:
11160951
12.

Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.

Kaminow L, Schimschock JR, Hammer AE, Vuong A.

Epilepsy Behav. 2003 Dec;4(6):659-66.

PMID:
14698699
13.

Lamotrigine for the treatment of epilepsy in childhood.

Besag FM, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G.

J Pediatr. 1995 Dec;127(6):991-7.

PMID:
8523205
14.

Add-on lamotrigine in pediatric epilepsy in India.

Jain R, Mishra D, Juneja M.

Indian Pediatr. 2011 Jan;48(1):55-8. Epub 2010 Aug 1.

PMID:
20453261
15.

Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: a 'proof of concept,' open label study.

Machado VH, Palmini A, Bastos FA, Rotert R.

Epilepsia. 2011 Jul;52(7):1303-10. doi: 10.1111/j.1528-1167.2011.03075.x. Epub 2011 Apr 19.

16.

Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.

Zeng K, Wang X, Xi Z, Yan Y.

Clin Neurol Neurosurg. 2010 May;112(4):291-5. doi: 10.1016/j.clineuro.2009.12.014. Epub 2010 Jan 13.

PMID:
20071075
17.

Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.

Aberg LE, Bäckman M, Kirveskari E, Santavuori P.

Epilepsia. 2000 Oct;41(10):1296-302.

18.

Lamotrigine as an add-on drug in typical absence seizures.

Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP.

Acta Neurol Scand. 1995 Mar;91(3):200-2.

PMID:
7793236
19.
20.

The management of refractory idiopathic epilepsies.

Perucca E.

Epilepsia. 2001;42 Suppl 3:31-5. Review.

Supplemental Content

Support Center